Research Project · Health
ADDF Diagnostics Accelerator Funding for FTD Biomarker Development
Alzheimer's Drug Discovery Foundationwww.alzdiscovery.org (opens in a new tab)Catalog updated
- Amount
- $5,000,000
- Program type
- Research Project
- Field
- Health
- Eligible career stages
- Not listed
About this program
The Association for Frontotemporal Degeneration (AFTD) partners with the Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) to fund cutting-edge biomarker development for frontotemporal dementia (FTD). The initiative has provided nearly $5 million through matched contributions from AFTD and ADDF to advance diagnostic tools and related research. Funding is intended for researchers pursuing FTD biomarker projects; specific applicant eligibility and application requirements are not provided in the available information.
In FundFit
FundFit names the researchers at your institution who match this program, and shows the eligibility rules, the announcement, and 4 similar programs in full.
Ask for a demo of this program The form opens already filled in.